Localised wedge shaped defects of the retinal nerve fibre layer in glaucomaJONAS, J. B; SCHIRO, D.British journal of ophthalmology. 1994, Vol 78, Num 4, pp 285-290, issn 0007-1161Article

Visibility of the normal retinal nerve fiber layer correlated with rim width and vessel caliberJONAS, J. B; SCHIRO, D.Graefe's archive for clinical and experimental ophthalmology. 1993, Vol 231, Num 4, pp 207-211, issn 0721-832XArticle

Localized retinal nerve fiber layer defects in nonglaucomatous optic nerve atrophyJONAS, J. B; SCHIRO, D.Graefe's archive for clinical and experimental ophthalmology. 1994, Vol 232, Num 12, pp 759-760, issn 0721-832XConference Paper

Retinale Nervenfaserschicht in Normal- und Glaukomaugen = Retinal nerve fiber layer (RNFL)JONAS, J. B; SCHIRO, D; NAUMANN, G. O. H et al.Der Ophthalmologe (Berlin. Print). 1993, Vol 90, Num 6, pp 603-612, issn 0941-293XArticle

Anaerobic susceptibility testing : slight differences in inoculum size can make a difference in minimum inhibitory concentrationsALDRIDGE, K. E; SCHIRO, D. D.Diagnostic microbiology and infectious disease. 1994, Vol 18, Num 3, pp 191-195, issn 0732-8893Article

In vitro activity of biapenem (L-627), a new carbapenem, against anaerobesALDRIDGE, K. E; MORICE, N; SCHIRO, D. D et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 4, pp 889-893, issn 0066-4804Article

In vitro antistaphylococcal acitivity and testing of RP 59500, a new streptogramin, by two methodsALDRIDGE, K. E; SCHIRO, D. D; VARNER, L. M et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 4, pp 854-855, issn 0066-4804Article

RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenemALDRIDGE, K. E; SCHIRO, D. D; SANDERS, C. V et al.Diagnostic microbiology and infectious disease. 1987, Vol 7, Num 1, pp 9-19, issn 0732-8893Article

Discordant results between the broth disk elution and broth microdilution susceptibility tests with Bacteroides fragilis group isolatesALDRIDGE, K. E; HENDERBERG, A; SCHIRO, D. D et al.Journal of clinical microbiology (Print). 1990, Vol 28, Num 2, pp 375-378, issn 0095-1137, 4 p.Article

The rapid emergence of fluoroquinolone-methicillin-resistant Staphylococcus aureus infections in a community hospital : an in vitro look at alternative antimicrobial agentsALDRIDGE, K. E; GELFAND, M. S; SCHIRO, D. D et al.Diagnostic microbiology and infectious disease. 1992, Vol 15, Num 7, pp 601-608, issn 0732-8893Article

Lomefloxacin, a new fluoroquinolone: studies on in vitro antimicrobial spectrum, potency, and development of resistanceALDRIDGE, K. E; HENDERBERG, A; GEBBIA, K et al.Diagnostic microbiology and infectious disease. 1989, Vol 12, Num 3, pp 221-233, issn 0732-8893Article

Ciprofloxacin (Bay o 9867): an in-vitro comparison with other broad spectrum antibioticsALDRIDGE, B. E; SCHIRO, D. D; TSAI, L et al.Current therapeutic research. 1985, Vol 37, Num 4, pp 754-762, issn 0011-393XArticle

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesALDRIDGE, K. E; GELFAND, M; JOHNSON, M et al.Diagnostic microbiology and infectious disease. 1994, Vol 18, Num 4, pp 235-241, issn 0732-8893Article